Expression of Cortactin and Focal Adhesion Kinase in Colorectal Adenocarcinoma: Correlation with Clinicopathologic Parameters and Their Prognostic Implication.
- Author:
Yo Na KIM
1
;
Ji Eun CHOI
;
Jun Sang BAE
;
Kyu Yun JANG
;
Myoung Ja CHUNG
;
Woo Sung MOON
;
Myoung Jae KANG
;
Dong Geun LEE
;
Ho Sung PARK
Author Information
1. Department of Pathology, Chonbuk National University Medical School, Jeonju, Korea. hspark@jbnu.ac.kr
- Publication Type:Original Article
- Keywords:
Colorectal neoplasms;
Cortactin;
Focal adhesion protein-tyrosine kinases;
Immunohistochemistry
- MeSH:
Actins;
Adenocarcinoma;
Calcium Hydroxide;
Colorectal Neoplasms;
Cortactin;
Focal Adhesion Protein-Tyrosine Kinases;
Focal Adhesions;
Humans;
Immunohistochemistry;
Mucous Membrane;
Proteins;
Zinc Oxide
- From:Korean Journal of Pathology
2012;46(5):454-462
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND: Cortactin and focal adhesion kinase (FAK) are two important components among actin cross-linking proteins that play a central role in cell migration. METHODS: The aims of this study were to evaluate the expression of cortactin and FAK in normal colorectal mucosa and colorectal adenocarcinoma (CRC) using tissue microarray of 2 mm cores to correlate their expression with other clinicopathological factors and, investigate their prognostic significance. RESULTS: Twenty (9%) and 24 cases (11%) of normal colorectal mucosa were immunoreactive for cortactin and FAK. In addition, 184 (84%) and 133 cases (61%) of CRCs were immunoreactive for cortactin and FAK, respectively. Cortactin expression was associated with histologic differentiation and FAK expression. Cortactin, but not FAK expression was also correlated with poor overall and relapse-free survival and served well as an independent prognostic factor for poor survival. CONCLUSIONS: Cortactin expression, in association with FAK expression, may plays an important role in tumor progression. Furthermore, it may also be a satisfactory biomarker to predict tumor progression and survival in CRC patients.
